Home > Healthcare > Pharmaceuticals > Finished Drug Form > Cytomegalovirus (CMV) Treatment Market

Cytomegalovirus (CMV) Treatment Market Size

Report ID: GMI8288
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Cytomegalovirus Treatment Market Size

Cytomegalovirus Treatment Market size was valued at USD 474.6 million in 2023 and is anticipated to register a CAGR of 6.6% between 2024 and 2032. This growth is propelled by increasing awareness and prevalence of CMV infection, as well as the development of new and effective treatments. For instance, according to the National Library of Medicine report of August 2023, CMV infects approximately 60% to 70% of adults in developed countries and nearly 100% in developing economies, driving demand for CMV treatment.

To get key market trends

Download Free Sample

Cytomegalovirus (CMV) treatment involves the use of antiviral drugs to manage CMV infections. CMV is a common virus known to cause serious complications, particularly in individuals with weakened immune systems such as those with HIV/AIDS, organ transplant recipients, and newborns. The primary goals of treatment are to alleviate symptoms, halt disease progression, and improve patient outcomes.

Cytomegalovirus Treatment Market Report Attributes
Report Attribute	Details
Base Year:	2023
Cytomegalovirus Treatment Market Size in 2023:	USD 474.6 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	6.6%
2032 Value Projection:	USD 828 Million
Historical Data for:	2018 - 2023
No. of Pages:	165
Tables, Charts & Figures:	261
Segments covered:	Drug Type, Application, Route of Administration, Distribution Channel, and Region
Growth Drivers:	Rise in the prevalence of cytomegalovirus infection Growing awareness and introduction of new drug therapies High prevalence of infectious diseases among AIDS patients Upsurge in patient pool of CMV retinitis and congenital CMV infection
Pitfalls & Challenges:	Adverse effects associated with cytomegalovirus drugs

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cytomegalovirus (CMV) treatment industry size reached USD 474.6 million in 2023 and is poised to expand at 6.6% CAGR from 2024-2032 propelled by increasing awareness and prevalence of CMV infection, as well as the development of new and effective treatments.

The ganciclovir drug type generated USD 162.5 million in revenue in 2023 and is estimated to record high demand by 2032 driven by the increasing number of solid organ and hematopoietic stem cell transplants globally.

North America CMV treatment market is set to exhibit robust growth between 2024 and 2032 owing to the increasing consumer awareness, growing incidences of cytomegalovirus infections, and the presence of key market players in the region.

Some of the major companies engaged in the CMV treatment industry are Chimerix, Clinigen Group PLC, F. Hoffmann-La Roche Ltd, Genentech Inc., Gilead Sciences, Inc., Merck & Co. Inc, Mylan N.V, Pfizer, Inc., Takeda Pharmaceuticals, Teva Pharmaceuticals Inc, and Thermo Fisher Scientific Inc.